Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on June 9, 2026

Jun. 9, 2026

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

Indeterminate GlobeNewswire

Jun. 9, 2026

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Indeterminate GlobeNewswire

Jun. 9, 2026

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

Jun. 9, 2026

New V2 Communications Research Reveals CEO Visibility Has Become a Business Imperative, Launches New Executive Visibility Services

Indeterminate GlobeNewswire

Jun. 9, 2026

Alliance Entertainment Celebrates Three AMPED Distribution Executives Named to Billboard's 2026 Indie Power Players List

Indeterminate GlobeNewswire

Jun. 9, 2026

American Cornerstone Institute Partners with Arkansas to Bring New Civics Resources to Educators in Celebration of America’s 250th Birthday

Indeterminate GlobeNewswire

Jun. 9, 2026

Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa

Indeterminate GlobeNewswire

Jun. 9, 2026

Creative Realities added to membership of Russell 3000® Index

Indeterminate GlobeNewswire

Jun. 9, 2026

Cineplex Reports Highest May Box Office since 2019

Indeterminate GlobeNewswire

Jun. 9, 2026

Ballou named among Europe's best PR agencies while expanding U.S. client portfolio

Indeterminate GlobeNewswire

Jun. 9, 2026

Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Jun. 9, 2026

Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board

Indeterminate GlobeNewswire

Jun. 9, 2026

Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream

Indeterminate GlobeNewswire

Jun. 9, 2026

BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board

Indeterminate GlobeNewswire

Jun. 9, 2026

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Indeterminate GlobeNewswire

Jun. 9, 2026

AB InBev Argentina x SeenThis: Michelob ULTRA wins fan attention on the road to FIFA World Cup 2026™

Indeterminate GlobeNewswire

Jun. 9, 2026

Parsons Secures a Total of $218 Million on AFRL GARDEM Contracts

Indeterminate GlobeNewswire

Jun. 9, 2026

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies

Indeterminate GlobeNewswire

Jun. 9, 2026

AI LIVE Announces First Speakers and Invites AI Leaders to Take the Stage

Indeterminate GlobeNewswire